<DOC>
	<DOCNO>NCT00383877</DOCNO>
	<brief_summary>This trial conduct China . This trial aim comparison effect glycemic control subject type 2 diabetes insulin detemir NPH-insulin give daily bedtime add-on oral anti-diabetic drug ( ) .</brief_summary>
	<brief_title>Effect Insulin Detemir Blood Glucose Control Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 2 diabetes HbA1C great 7.5 % less equal 11.0 % Currently oral antidiabetic drug ( OAD ) equal 3 month Previous acute treatment insulin 7 day . Treatment OAD ( ) adhere approval labeling . Proliferate retinopathy maculopathy require acute treatment within last year . Known hypoglycaemia unawareness recurrent major hypoglycaemia , may interfere study participation judge Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>